VERO Biotech

Pharmaceutical Manufacturing • Atlanta, Georgia, United States • 201-500 Employees

Company overview

Headquarters	387 Technology Circle NW, 125, Atlanta, GA 30313, US
Phone number	+13217852460
Websites	vero-biotech.com genollc.com
NAICS	3254
SIC	384
Employees	201-500
Socials

Key Contacts at VERO Biotech

Clayton Santiago

Senior Director Of Strategic Accounts And Marketing

Cynthia Wright

Director Head Of Human Resources

Kevin Friedman

Medical Director, Head Of Medical Affairs And Pharmacovigilance

Migdalia Cruz

Supply Chain Director

Christopher D. Johnson

Director Of National Accounts

Brandon Longshore

Senior Director Facilities Operations

Alex Layyous

Director, Console Engineering

Kyle Galenski

Director Of Commercial Operations And Marketing

Marat Rikelman

Senior Director Software Development

Leigh Davis

Director, Supply Chain

VERO Biotech Email Formats

VERO Biotech uses 2 email formats. The most common is {first name}.{last name} (e.g., john.doe@vero-biotech.com), used 51.5% of the time.

Format	Example	Percentage
{first name}.{last name}	john.doe@vero-biotech.com	51.5%
{first initial}.{last name}	j.doe@vero-biotech.com	46.3%

About VERO Biotech

Vero biotech is an emerging biotechnology company focused on the design, development, and commercialization of next generation inhaled nitric oxide (NO) delivery systems to address unmet medical needs of patients with cardiopulmonary conditions. At Vero Biotech, our mission is to improve the lives of patients by leading the development of innovative technologies for inhaled NO delivery in the acute care hospital setting and beyond, wherever Nitric Oxide treatment is needed. We strive to exceed customer expectations in terms of safety, efficacy, and growth by focusing on the science, development, and commercialization of our innovations.

VERO Biotech revenue & valuation

Annual revenue	$9,500,000
Revenue per employee	$48,000
Estimated valuation?This valuation is estimated based on industry average for the Pharmaceutical Manufacturing industry and current estimated revenues	$30,400,000
Total funding	$30,000,000